SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of AN2 Therapeutics, Inc. (NASDAQ: ANTX)

PR Newswire

NEW YORK, July 20, 2026

NEW YORK , July 20, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating AN2 Therapeutics, Inc. (NASDAQ: ANTX) on behalf of the company's shareholders. The investigation seeks to determine whether AN2 Therapeutics's directors breached their fiduciary duties in connection with recent corporate actions.

Purcell & Lefkowitz LLP

If you are a shareholder of AN2 Therapeutics and are interested in obtaining additional information about your rights and options, please visit us at:  https://pjlfirm.com/an2-therapeutics-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com  or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud , breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com . Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE Purcell & Lefkowitz LLP

Läs mer på PR Newswire

Ämnen i artikeln

AN2 Therapeutics

Senast

4,84

1 dag %

3,42%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån